feed,title,long_url,short_url
Benzinga,Global Rituximab Biosimilars Market Report 2020: Market is Expected to Recover and Reach $2.62 Billion in 2023 at a CAGR of 13.85% - Forecast to 2030 - ResearchAndMarkets.com,https://www.benzinga.com/pressreleases/21/01/b19074628/global-rituximab-biosimilars-market-report-2020-market-is-expected-to-recover-and-reach-2-62-billi,https://j.mp/2XoGJfG
